Worrying results from genotyping quality assessments

Inequalities in immuno-oncology access across Europe

Measuring innovation and value in healthcare systems

Could personalised medicine increase inequality to medicine access?

The economics of personalised medicine in low and middle income countries

Accelerating research to the bedside

The Innovative Medicines Initiative

Genetically profiling entire populations, starting with Estonia

Approaches to screening and early detection across Europe

Connecting personalised medicine research in Canada with Europe

Effective implementation of personalised medicine guidelines

The importance of data connectivity and e-health